-
Mashup Score: 0American Academy of Dermatology Reveals New Acne Vulgaris Guidelines - 2 month(s) ago
In new guidelines by the AAD, 18 new evidence-based recommendations and 5 practice statements were described for patients 9 years of age and older with acne.
Source: www.hcplive.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 0Scarring Alopecia: Cosmetic and Procedural Interventions - 1 year(s) ago
Ronda S. Farah, MD, kicked off the session “Cosmetic and Procedural Interventions for Scarring Alopecia,” at the 2023 AAD Annual Meeting, by reviewing the evidence for scarring alopecia.
Source: HMP Global Learning NetworkCategories: Dermatology, Latest HeadlinesTweet-
Ronda S. Farah, MD, kicked off the session “Cosmetic and Procedural Interventions for Scarring Alopecia,” at the 2023 AAD Annual Meeting, by reviewing the evidence for scarring alopecia. Read More: https://t.co/MfsePG3DzF #dermtwitter #dermatology #alopcia #AAD
-
-
Mashup Score: 0
Posters presented at the American Academy of Dermatology 2023 Annual Meeting provided a snapshot of disparities in dermatology care, both in terms of geographic differences in access to care and collection of race/ethnicity data in clinical trials.
Source: AJMCCategories: General Medicine Journals and Societies, Latest HeadlinesTweet-
Posters presented at the @AADskin 2023 Annual Meeting provide a snapshot of disparities in #dermatology care. #AAD Read more! https://t.co/G3ksQCia30 https://t.co/rudENmhcII
-
-
Mashup Score: 1Frontal Fibrosing Alopecia Pathogenesis - 1 year(s) ago
At the 2023 AAD Annual Meeting, Maria K. Hordinsky, MD, FAAD, kicked off her session, “Frontal Fibrosing Alopecia (FFA) Pathogenesis—Present, Past and Future,” with the clinical difference between lichen planopilaris and FFA.
Source: HMP Global Learning NetworkCategories: Dermatology, Latest HeadlinesTweet-
At the 2023 AAD Annual Meeting, Maria K. Hordinsky, MD, FAAD, kicked off her session, “Frontal Fibrosing Alopecia (FFA) Pathogenesis—Present, Past and Future,” with the clinical difference between lichen planopilaris and FFA. https://t.co/32si6ejEou #dermtwitter #FFA #AAD
-
-
Mashup Score: 0Dr John Harris Outlines the Outcomes of Stopping Treatment With Ruxolitinib Cream for Vitiligo - 1 year(s) ago
Similar to other therapies, approximately 40% of patients with vitiligo who stopped treatment with ruxolitinib cream relapsed, but they achieved repigmentation once treatment was reinitiated, explained John Harris, MD, PhD, FAAD, director of the Vitiligo Clinic and Research Center at UMass Chan Medical School.
Source: AJMCCategories: General Medicine Journals and Societies, Latest HeadlinesTweet-
Tune in to this @AJMC_Journal interview as Dr John Harris (@HarrisVitiligo) discusses the treatment of #Ruxolitinib cream for #vitiligo, which he presented at the 2023 @AADskin conference. #AAD Watch now! https://t.co/9amN8TGiBc https://t.co/5DVw1erpJ6
-
-
Mashup Score: 0Experts Herald “Year of the JAK Inhibitor” in Dermatology - 1 year(s) ago
A symposium at the American Academy of Dermatology 2023 Annual Meeting convened speakers who presented current data on the use of Janus kinase (JAK) inhibitors in dermatology, including in atopic dermatitis and vitiligo.
Source: AJMCCategories: General Medicine Journals and Societies, Latest HeadlinesTweet-
A symposium at the @AADskin 2023 Annual Meeting convened speakers who presented current data on the use of Janus kinase (JAK) inhibitors in dermatology, including in #AtopicDermatitis and #vitiligo. #AAD Read now! https://t.co/Ob5VD5JXAx https://t.co/3intdsNOIA
-
-
Mashup Score: 3How to: Antiarrhythmika in der klinischen Anwendung - Herzschrittmachertherapie + Elektrophysiologie - 1 year(s) ago
Antiarrhythmic drugs are important for the noninvasive rhythm control therapy of heart rhythm disorders. Antiarrhythmic drugs, which can be categorized into subgroups based on their different effects on ion channels, are clinically used for various types of arrhythmias. Knowledge about these specific electrophysiological effects contributes to a better understanding in order to select the correct…
Source: SpringerLinkCategories: Cardiologists, Latest HeadlinesTweet-
Nizar Karfoul Antiarrhythmic drugs #AAD What is new? Great feature of: https://t.co/0gJ0U4DGHo @SpringerNature @HenrikeHillmann @BetzKonstanze @DavidDuncker @JBauersachsMD @SHohmannMD https://t.co/2xlLuddFp5
-
-
Mashup Score: 0Exploring the Diagnosis and Management of Agitation in Alzheimer's Disease: An Assessment of Practice - 1 year(s) ago
Test your knowledge: Are you able to recognize and manage agitation in Alzheimer’s disease (AAD)?
Source: MedscapeCategories: Latest Headlines, PsychiatryTweet-
📝 Test your knowledge: Are you able to recognize and manage agitation in Alzheimer's disease? #AAD #MedEd #CME #MedTwitter #PsychTwitter ➡️ https://t.co/fbzHDbCtmS https://t.co/IikFWEr0uA
-
-
Mashup Score: 0Exploring the Diagnosis and Management of Agitation in Alzheimer's Disease: An Assessment of Practice - 1 year(s) ago
Test your knowledge: Are you able to recognize and manage agitation in Alzheimer’s disease (AAD)?
Source: MedscapeCategories: Latest Headlines, PsychiatryTweet-
📝 Test your knowledge: Are you able to recognize and manage agitation in #Alzheimer's disease? #AAD #MedEd #CME #MedTwitter #PsychTwitter ➡️ https://t.co/Di932XFDVi https://t.co/2BpBx1hO23
-
-
Mashup Score: 0
What is agitation in Alzheimer’s disease (AAD)? Why is it important? Drs Porsteinsson, Culpepper, and Atri discuss ways to manage this distressing symptom.
Source: MedscapeCategories: Latest Headlines, NeurologyTweet-
📍 What is agitation in #Alzheimer's disease? Why is it important? Experts discuss ways to manage this distressing symptom. #AAD #MedEd #CME #MedTwitter #NeuroTwitter ➡️ https://t.co/dV9Odaq6UA https://t.co/kEi6QseNsM
-
In new guidelines by the #AAD, 18 new evidence-based recommendations and 5 practice statements were described for patients 9 years of age and older with acne. https://t.co/Hi1RwCeW3j https://t.co/48SZp9uM8U